LH-021

N/A

Report date: 2023/01/03 11:10:04
NME

Base Information

Drug NameLH-021
Drug Alias NameLH-021BBT-02
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionBone morphogenetic protein 2 modulators
TargetsBone morphogenetic protein 2
Therapy Area/IndicationsOsteoarthritisCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLink Health Group
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLink Health Group
Inactive CompaniesN/A
Active IndicationsOsteoarthritisCartilage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A